PharmTech News

Articles

A number of experts will be examining investment opportunities within the evolving cell and gene therapy sector, in a panel discussion on Wednesday morning (Nov. 6, 2019) during CPhI Worldwide in Frankfurt, Germany.

Investing in Cell and Gene Technology

The second part of CPhI’s annual report has projected that the biologic manufacturing capacity of Europe will exceed that of the United States by 2023, as a result of the rising number of commercially approved biologics.


Europe’s Biologic Manufacturing Capacity Shows Potential, According to CPhI Report

According to the third part of the CPhI annual report, a lack of cell and gene expertise may be a drag factor on the sector and a spike in biological therapeutics development is driving bio demand in China.


CPhI Report Predicts Cell and Gene Expertise Shortfall and Growth in China Bio

The new Javené, France-based facility is expected to increase the company’s production capacity of injectable grade sodium hyaluronate obtained by fermentation by 2.5 times.

HTL to Invest in Production Facility for Injectable Grade Sodium Hyaluronate

Ashland will be presenting new devices at booth 102B13 at CPhI Worldwide. 

Ashland to Present New Pharma Solutions at CPhI Worldwide 2019

Dr. Ger Brophy, executive vice president, Biopharma Production for Avantor, will deliver the keynote address at the conference and Claudia Berrón, senior vice president, Business Development and Commercial Operations for Avantor, will discuss on leveraging biopharma 4.0 to reconstruct the biopharma supply chain and manufacturing practices.

Avantor Technical Experts to Share Cell and Gene Therapy Production Insight at CPhI Worldwide 2019

The company will showcase its RayDyLyo all-plastic capping solution, which works in conjunction with SCHOTT’s adaptiQ ready-to use (RTU) vials and groninger Nestfillers by providing maximum flexibility for fill/finish operations.

ARaymondlife to Present Fill/Finish Solutions at CPhI Worldwide 2019

During the Tuesday afternoon (Nov. 5, 2019) at CPhI, Maurits Janssen (senior director, head of commercial development at Lonza) will guide the audience through the complexities and best practices of moving from small molecule to biologics into antibody drug conjugates (ADCs).

Taking Complexity to the Next Level

To address the potential medicines of tomorrow, a panel of experts will discuss emerging therapies and the potential of developing new medicines and repurposing old medicines on Tuesday Nov. 5, 2019 at CPhI in Frankfurt, Germany. 

Tomorrow’s World in Medicines

The company believes the investment will improve its support of clients’ research, development, and clinical manufacturing needs by expanding its development and manufacturing capacity.

CPhI News